Tagalog, Almie Rose .
HRN: 18-98-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CO-AMOXICLAV 625MG (TAB)
10/20/2023
10/27/2023
PO
1 Tab
BID
SP NSVD W REPAIR; UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes